Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2021-03-23 Capital/Financing Update
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication from the company Rossari Biotech Limited to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on March 23, 2021. The key content includes approval of a preferential allotment of equity shares and the approval to convene an Extraordinary General Meeting (EGM) to seek shareholder approval for the preferential issue. The document includes detailed disclosures as required under SEBI regulations about the preferential issue, including number of shares, pricing, and proposed investors. This is a regulatory announcement about capital raising activities and corporate actions, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the capital issuance decision. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2021-03-23 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter from Rossari Biotech Limited addressed to stock exchanges (BSE and NSE) clarifying an inquiry about an increase in trading volume of the company's shares. It references a regulatory letter from NSE and states that there is no pending information or announcement that would affect share price or volume. The letter is signed by the Company Secretary & Compliance Officer. The content is a regulatory compliance communication responding to a surveillance query, not a financial report, earnings release, or management discussion. The document length is short (2571 characters) and it is a direct regulatory response. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2021-03-22 English
Board Meeting — Fund Raising
Regulatory Filings Classification · 95% confidence The document text is extremely short (597 characters) and contains only address and contact information related to stock exchanges and listing compliance. There is no substantive financial data, report content, or detailed information. It appears to be a brief regulatory or compliance-related communication without any report or announcement of voting results, management changes, or financial disclosures. Given the lack of detailed content and the nature of the text, it best fits the category of a Regulatory Filing (RNS), which is a fallback for miscellaneous filings that do not fit other categories.
2021-03-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the schedule of investor and analyst conferences attended by the company. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The letter mentions that the discussions were based on a previously submitted 'Earnings Presentation' but does not contain any financial data or detailed financial results itself. The document is short (2617 characters) and serves as an announcement of participation in investor conferences rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure.
2021-03-08 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document text is extremely short (593 characters) and contains only address and contact information related to stock exchanges and listing compliance. There is no substantive financial data, report content, or detailed information. It appears to be a brief regulatory or compliance communication without any report or announcement of voting results, management changes, or financial disclosures. Given the lack of specific report content and the nature of the text, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2021-02-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.